169. Hypothalamic-Pituitary Pathophysiology Flashcards
Caused by:
- h/o infarction, surgery, irradiation of tumor
- medical therapy of tumor
- end stage of hypophysitis
Results in hypopituitarism, rare visual defects, CSF in sella turcica
Secondary Empty Sella Syndrome
Clinical manifestations d/t direct or associated hormone effects
Women:
- oligo-amenorrhea/infertility
- galactorrhea
- estrogen deficiency
- osteopenia
- diminished libido/dyspareunia
- acne/hirsutism
Men:
- decreased libido
- ED
- gynecomastia
- galactorrhea
- infertility
- osteopenia
Hyperprolactinemia
Medical therapy for acromegaly
Cabergoline - dopamine agonist
Octreotide, lanreotide - somatostatin analogs
Pegvisomant - GH Receptor antagonist
Resistance to ADH
- defective V2 receptor signaling
- congenital defect
Caused by:
- drugs
- hypercalciuria
- hypokalemia
- mutation of V2 receptor
- Aquaporin 2 mutation
Nephrogenic Diabetes Insipidus
Over 90% in women Associated w/ multiple hormonal abnormalities:
- Hypogonadotrophic hypogonadism (amenorrhea)
- Early satiety
- Temp dysregulation (hypothermia)
Hormonal abnormalities reversible w/ weight gain
Anorexia nervosa
Dopamine agonists used to treat hyperprolactinemia
Efficacious in normalizing prolactin levels
Efficacious in shrinking tumors
Cannot nurse while on these medications d/t suppressed prolactin
Cabergoline and bromocriptine
Manifestations:
- prepubertal
- postpubertal
Diagnosis:
- measure LH, FSH, estradiol, testosterone
Common:
- mass lesions
- reversible weight loss and increased exercise
- idiopathic
Treatment:
- Men: testosterone
- Women: birth control
- Women wanting to be pregnant: stimulate gonad w/ gonadotrophins
Gonadotrophin deficiency
Associated w/ failure of postpartum lactation
Usually associated with loss of other hormones
- Sheehan’s syndrome
- Lymphocytic hypophysitis
- ACTH loss
- other mass lesions of the sella
NO treatment
Hypoprolactinemia
Clinical characteristics:
- male >> female
- >40yo
Normal past history of gonadal function
- normal puberty and fertility
Enormous pituitary size causing mass effects
- visual field defects
- hypopituitarism
- hyperprolactinemia
- extrasellar extension on MRI
Can make isolated alpha and beta subunits or intact LH or intact FSH
Gonadotroph adenomas
HA Visual field defects
Cranial nerve palsies
Hypopituitarism
Diabetes Insipidus
Temp dysregulation and dysregulation of food intake (rare)
Mass effects of sellar lesions
Congenital malformations
- often related to transcription factor mutations
Hydrocephalus Tumors
- craniopharyngiomas
- pituitary adenomas
- dysgerminomas Trauma
- surgery
- irradiation
- external Infiltrative disease
- sarcoidosis
- Langerhans cell histiocytosis
Inflammation/infection
- encephalitis
- meningitis
Etiology of Hypothalamic Dysfunction
Manifestation:
secondary hypoadrenalism
- lose cortisol and adrenal androgens
- aldosterone relatively normal (from RAS)
- Na+ low from lack of cortisol
- K+ normal bc aldosterone is normal
Inability to respond to stress
- failure to treat –> death
Diagnosis:
- low cortisol and ACTH
- decreased response to hypoglycemia
- decrease cortisol response to injection Cotrosyn (synthetic ACTH) if chronic condition —> normal response if acute condition
ACTH deficiency
Inability to suppress GH levels during an oral glucose tolerance test
Elevated serum IGF-1 levels MRI to identify location, size of tumor
- 60% macroadenomas
Visual fields if tumor found to be abutting chiasm
Evaluate for hypopituitarism if macroadenoma
Diagnostic testing for acromegaly
Normally caused by a pituitary tumor
- also caused by a craniopharyngioma
- can also be idiopathic
Increased fat mass
Decreased muscle mass
Decreased energy, increased fatigue
Poor QOL
Adult GH deficiency
Medical therapies for Cushing’s
Steroidogenesis blockers
Steroid receptor antagonist
GH receptor antagonist used to treat acromegaly
Less activation –> less IGF-1 production
Pegvisomant
Deficiency of vasopressin secretion or action
Polyuria - large volume of dilute urine
Polydipsia - increased thirst
Diabetes Insipidus
Hypopituitarism
Disordered vasopressin regulation
Hyperprolactinemia
Other hypothalamic dysfunction if very large and bilateral
- food intake
- temperature dysregulation
Manifestations of hypothalamic disease
Mutation in Type 1A subunit of Protein Kinase A (PRKAR1A)
Pituitary adenoma in 10% (GH producing)
Spotty skin pigmentation
Myxomas
Schwannomas
Pigmented nodular adrenal cortical disease causing Cushing’s syndrome in 30%
Carney Complex
Mutations in HESX1, SOX2, SOX3, OTX2
Absent septum pellucidum
Agenesis of corpus callosum
Optic nerve dysplasia
Hypothalamic developemental dysfunction leads to hypopituitarism
Variable presentation
Septo-Optic Dysplasia
Pituitary transcription factor mutation of __ GH, TSH, PRL deficiencies
Pit-1
Infiltrative hypothalamic disease
- often presents in middle age
May be pulmonary interstitial disease
- get diffusing capacity measurement
Osteolytic lesions, especially in jaw
Treat w/ alkylating agents, focal irradiation, vinca alkaloids
Langerhans Cell Histiocytosis
Asymptomatic Symptomatic d/t mass effects
Primary therapy is surgery
Nonfunctional pituitary adenomas